VEGFA and neoplasm: Indeed, two general modes of resistance to angiogenesis inhibitors targeting the VEGF pathway have been proposed: adaptive (evasive) resistance, which occurs after a period of tumor control, and intrinsic (pre-existing) non-responsiveness without any therapeutic benefit [15].